153 related articles for article (PubMed ID: 20554750)
1. Killing the killer: natural killer cells to treat Ewing's sarcoma.
Ahn YO; Weigel B; Verneris MR
Clin Cancer Res; 2010 Aug; 16(15):3819-21. PubMed ID: 20554750
[TBL] [Abstract][Full Text] [Related]
2. Ewing's sarcoma: ex vivo sensitivity towards natural and lymphokine-activated killing.
Atzpodien J; Gulati SC; Shimazaki C; Bührer C; Oz S; Kwon JH; Kolitz JE; Clarkson BD
Oncology; 1988; 45(6):437-43. PubMed ID: 3263598
[TBL] [Abstract][Full Text] [Related]
3. Enhancing Natural Killer Cell Targeting of Pediatric Sarcoma.
Omer N; Nicholls W; Ruegg B; Souza-Fonseca-Guimaraes F; Rossi GR
Front Immunol; 2021; 12():791206. PubMed ID: 34804076
[TBL] [Abstract][Full Text] [Related]
4. NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways.
Verhoeven DH; de Hooge AS; Mooiman EC; Santos SJ; ten Dam MM; Gelderblom H; Melief CJ; Hogendoorn PC; Egeler RM; van Tol MJ; Schilham MW; Lankester AC
Mol Immunol; 2008 Sep; 45(15):3917-25. PubMed ID: 18657862
[TBL] [Abstract][Full Text] [Related]
5. Prospects and Advances in Adoptive Natural Killer Cell Therapy for Unmet Therapeutic Needs in Pediatric Bone Sarcomas.
Bareke H; Ibáñez-Navarro A; Guerra-García P; González Pérez C; Rubio-Aparicio P; Plaza López de Sabando D; Sastre-Urgelles A; Ortiz-Cruz EJ; Pérez-Martínez A
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176035
[TBL] [Abstract][Full Text] [Related]
6. Potential approaches to the treatment of Ewing's sarcoma.
Yu H; Ge Y; Guo L; Huang L
Oncotarget; 2017 Jan; 8(3):5523-5539. PubMed ID: 27740934
[TBL] [Abstract][Full Text] [Related]
7. Anti-EGFR antibody cetuximab enhances the cytolytic activity of natural killer cells toward osteosarcoma.
Pahl JH; Ruslan SE; Buddingh EP; Santos SJ; Szuhai K; Serra M; Gelderblom H; Hogendoorn PC; Egeler RM; Schilham MW; Lankester AC
Clin Cancer Res; 2012 Jan; 18(2):432-41. PubMed ID: 22090361
[TBL] [Abstract][Full Text] [Related]
8. The Ewing's sarcoma family of tumors: Ewing's sarcoma and peripheral primitive neuroectodermal tumor of bone and soft tissue.
Granowetter L; West DC
Cancer Treat Res; 1997; 92():253-308. PubMed ID: 9494764
[No Abstract] [Full Text] [Related]
9. Endothelioma of bone; Ewing's sarcoma.
COLEY BL; HIGINBOTHAM NL; BOWDEN L
Ann Surg; 1948 Sep; 128(3):533-60. PubMed ID: 18889550
[No Abstract] [Full Text] [Related]
10. The irony of highly-effective bacterial therapy of a patient-derived orthotopic xenograft (PDOX) model of Ewing's sarcoma, which was blocked by Ewing himself 80 years ago.
Murakami T; Kiyuna T; Kawaguchi K; Igarashi K; Singh AS; Hiroshima Y; Zhang Y; Zhao M; Miyake K; Nelson SD; Dry SM; Li Y; DeLong JC; Lwin TM; Chishima T; Tanaka K; Bouvet M; Endo I; Eilber FC; Hoffman RM
Cell Cycle; 2017 Jun; 16(11):1046-1052. PubMed ID: 28296559
[TBL] [Abstract][Full Text] [Related]
11. Ewing's sarcoma of the hand: localization and treatment.
Euler E; Wilhelm K; Permanetter W; Kreusser T
J Hand Surg Am; 1990 Jul; 15(4):659-62. PubMed ID: 2380532
[TBL] [Abstract][Full Text] [Related]
12. Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D.
Sayitoglu EC; Georgoudaki AM; Chrobok M; Ozkazanc D; Josey BJ; Arif M; Kusser K; Hartman M; Chinn TM; Potens R; Pamukcu C; Krueger R; Zhang C; Mardinoglu A; Alici E; Temple HT; Sutlu T; Duru AD
Front Immunol; 2020; 11():40. PubMed ID: 32082316
[TBL] [Abstract][Full Text] [Related]
13. Targeted therapies in Ewing's sarcoma.
Scotlandi K
Adv Exp Med Biol; 2006; 587():13-22. PubMed ID: 17163152
[TBL] [Abstract][Full Text] [Related]
14. A humanized orthotopic mouse model for preclinical evaluation of immunotherapy in Ewing sarcoma.
Luo W; Hoang H; Liao Y; Pan J; Ayello J; Cairo MS
Front Immunol; 2023; 14():1277987. PubMed ID: 37868989
[TBL] [Abstract][Full Text] [Related]
15. Ewing's sarcoma.
Eggli KD; Quiogue T; Moser RP
Radiol Clin North Am; 1993 Mar; 31(2):325-37. PubMed ID: 8446752
[TBL] [Abstract][Full Text] [Related]
16. Oncological outcomes of patients with Ewing's sarcoma: is there a difference between skeletal and extra-skeletal Ewing's sarcoma?
Pradhan A; Grimer RJ; Spooner D; Peake D; Carter SR; Tillman RM; Abudu A; Jeys L
J Bone Joint Surg Br; 2011 Apr; 93(4):531-6. PubMed ID: 21464495
[TBL] [Abstract][Full Text] [Related]
17. The Ewing family of tumors. Ewing's sarcoma and primitive neuroectodermal tumors.
Grier HE
Pediatr Clin North Am; 1997 Aug; 44(4):991-1004. PubMed ID: 9286296
[TBL] [Abstract][Full Text] [Related]
18. Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survival.
Picarda G; Lamoureux F; Geffroy L; Delepine P; Montier T; Laud K; Tirode F; Delattre O; Heymann D; Rédini F
Clin Cancer Res; 2010 Apr; 16(8):2363-74. PubMed ID: 20371692
[TBL] [Abstract][Full Text] [Related]
19. Clinical oncology: case presentations from oncology centres. 1. Ewing's sarcoma. The London Bone Tumour Service.
Stein RC; Cannon S; Cassoni A; Pringle JS; Stoker DJ; Souhami RL
Eur J Cancer; 1991; 27(11):1525-33. PubMed ID: 1835871
[TBL] [Abstract][Full Text] [Related]
20. Ewing's sarcoma: presentation and management.
Weber KL; Sim FH
J Orthop Sci; 2001; 6(4):366-71. PubMed ID: 11479768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
